Stratec (SBS) Q2 2025 earnings summary

Executive summary

• H1 2025 sales grew 5.2% year-over-year to €118.6 million, driven by strong development activity and stabilization in Analyzer Systems, though FX impacts pressured margins.

• Gross margin remained stable despite rising input costs and negative currency effects.

• Significant progress in development partnerships and a strong increase in the deal pipeline for system development.

• Industry sentiment improved post-ADLM congress, with increased innovation appetite and infrastructure investment.

• Customers are extending instrument lifecycles, investing more in maintenance, but a recovery in demand is visible as inventories normalize.

Financial highlights

• H1 2025 sales rose 5.2% year-over-year to €118.6 million (+5.8% at constant currency); Q2 sales dipped 1% to €58.2 million.

• Adjusted EBIT margin fell 160 bps to 7.2% in H1; adjusted EBIT was €8.5 million, down 14.1% year-over-year.

• Adjusted EBITDA declined 7.8% to €16.1 million; adjusted consolidated net income dropped 11.2% to €5.0 million; adjusted EPS was €0.41.

• Operating cash flow was -€5.8 million, mainly due to lower net income, high tax payments, and increased inventories.

• Free cash flow was -€14.7 million; net debt to adjusted EBITDA rose to 2.3x; cash position decreased to €18.7 million.

Outlook and guidance

• Full-year 2025 guidance confirmed: sales growth in low to mid-single digits (constant currency), adjusted EBIT margin of 10%-12%.

• H2 expected to be back-end loaded, with significant acceleration in Analyzer Systems sales and improved EBIT margin.

• Investments in tangible and intangible assets projected at 8%-10% of sales.

• Focus remains on cost discipline, executing deal pipeline, and market expansion.

• Forecasts subject to increased uncertainty due to post-pandemic effects, geopolitical risks, and customer order volatility.